2,4,6-Triphenylaniline

2,4,6-Triphenylaniline has anti-diabetic activity and can be encapsulated in nano-emulsions (NE) to enhance stability and permeability. The NE loaded with 2,4,6-Triphenylaniline inhibits α-glucosidase and α-amylase[1].

Product Specifications

CAS Number

[6864-20-6]

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Amylases; Glycosidase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/2-4-6-triphenylaniline.html

Purity

99.81

Smiles

NC1=C(C2=CC=CC=C2)C=C(C3=CC=CC=C3)C=C1C4=CC=CC=C4

Molecular Formula

C24H19N

Molecular Weight

321.42

Precautions

H315, H319, H335

References & Citations

[1]Nathiya Ranganathan, et al. 2,4,6-Triphenylaniline nanoemulsion formulation, optimization, and its application in type 2 diabetes mellitus. J Cell Physiol. 2019 Dec;234 (12) :22505-22516.